Literature DB >> 12946886

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

A John Rush1, Madhukar H Trivedi, Hicham M Ibrahim, Thomas J Carmody, Bruce Arnow, Daniel N Klein, John C Markowitz, Philip T Ninan, Susan Kornstein, Rachel Manber, Michael E Thase, James H Kocsis, Martin B Keller.   

Abstract

The 16-item Quick Inventory of Depressive Symptomatology (QIDS), a new measure of depressive symptom severity derived from the 30-item Inventory of Depressive Symptomatology (IDS), is available in both self-report (QIDS-SR(16)) and clinician-rated (QIDS-C(16)) formats. This report evaluates and compares the psychometric properties of the QIDS-SR(16) in relation to the IDS-SR(30) and the 24-item Hamilton Rating Scale for Depression (HAM-D(24)) in 596 adult outpatients treated for chronic nonpsychotic, major depressive disorder. Internal consistency was high for the QIDS-SR(16) (Cronbach's alpha =.86), the IDS-SR(30) (Cronbach's alpha =.92), and the HAM-D(24) (Cronbach's alpha =.88). QIDS-SR(16) total scores were highly correlated with IDS-SR(30) (.96) and HAM-D(24) (.86) total scores. Item-total correlations revealed that several similar items were highly correlated with both QIDS-SR(16) and IDS-SR(30) total scores. Roughly 1.3 times the QIDS-SR(16) total score is predictive of the HAM-D(17) (17-item version of the HAM-D) total score. The QIDS-SR(16) was as sensitive to symptom change as the IDS-SR(30) and HAM-D(24), indicating high concurrent validity for all three scales. The QIDS-SR(16) has highly acceptable psychometric properties, which supports the usefulness of this brief rating of depressive symptom severity in both clinical and research settings.

Entities:  

Mesh:

Year:  2003        PMID: 12946886     DOI: 10.1016/s0006-3223(02)01866-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  1100 in total

1.  A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.

Authors:  E Sherwood Brown; Prabha Sunderajan; Lisa T Hu; Sharon M Sowell; Thomas J Carmody
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Feasibility of an HIV/STI Risk-Reduction Program for Incarcerated Women Who Have Experienced Interpersonal Violence.

Authors:  Jennifer E Johnson; Marlanea E Peabody; Wendee M Wechsberg; Rochelle K Rosen; Karen Fernandes; Caron Zlotnick
Journal:  J Interpers Violence       Date:  2014-11-12

3.  What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?

Authors:  Jackie K Gollan; Maurizio Fava; Benji Kurian; Stephen R Wisniewski; A John Rush; Ella Daly; Sachiko Miyahara; Madhukar H Trivedi
Journal:  Depress Anxiety       Date:  2011-12-06       Impact factor: 6.505

4.  Adaptation of problem-solving treatment for prevention of depression among low-income, culturally diverse mothers.

Authors:  Emily Feinberg; Rachel Stein; Yaminette Diaz-Linhart; Lucia Egbert; William Beardslee; Mark T Hegel; Michael Silverstein
Journal:  Fam Community Health       Date:  2012 Jan-Mar

5.  Heterogeneity in Fear Processing across and within Anxiety, Eating, and Compulsive Disorders.

Authors:  Abby J Fyer; Franklin R Schneier; Helen Blair Simpson; Tse Hwei Choo; Stephanie Tacopina; Marcia B Kimeldorf; Joanna E Steinglass; Melanie Wall; B Timothy Walsh
Journal:  J Affect Disord       Date:  2020-07-22       Impact factor: 4.839

6.  Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study.

Authors:  Patience J Gallagher; Victor Castro; Maurizio Fava; Jeffrey B Weilburg; Shawn N Murphy; Vivian S Gainer; Susanne E Churchill; Isaac S Kohane; Dan V Iosifescu; Jordan W Smoller; Roy H Perlis
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

7.  Lessons learned from study of depression in cardiovascular patients in an acute-care heart and vascular hospital.

Authors:  Michael Davis; J Michael Brennan; Nancy Vish; Jenny Adams; Mary Muldoon; Tara Renbarger; John Garner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

8.  Patient learning of treatment contents in cognitive therapy.

Authors:  Nicole B Gumport; Lu Dong; Jason Y Lee; Allison G Harvey
Journal:  J Behav Ther Exp Psychiatry       Date:  2017-08-31

9.  A pilot randomized controlled trial comparing prenatal yoga to perinatal health education for antenatal depression.

Authors:  Lisa A Uebelacker; Cynthia L Battle; Kaeli A Sutton; Susanna R Magee; Ivan W Miller
Journal:  Arch Womens Ment Health       Date:  2015-09-18       Impact factor: 3.633

10.  A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.

Authors:  Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.